msi-1436 and Atherosclerosis

msi-1436 has been researched along with Atherosclerosis* in 1 studies

Other Studies

1 other study(ies) available for msi-1436 and Atherosclerosis

Article	Year
Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR Clinical science (London, England : 1979), 2017, Oct-01, Volume: 131, Issue:20 Topics: AMP-Activated Protein Kinases; Animals; Aorta; Aortic Diseases; Atherosclerosis; Biomarkers; Blood Glucose; Chemokine CCL2; Cholestanes; Cholesterol; Diet, High-Fat; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Genetic Predisposition to Disease; Homeostasis; Male; Mice, Knockout; Phenotype; Phosphorylation; Plaque, Atherosclerotic; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-akt; Receptors, LDL; Signal Transduction; Spermine; Time Factors; Triglycerides; Weight Loss	2017

Article

Year

Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR

Clinical science (London, England : 1979), 2017, Oct-01, Volume: 131, Issue:20

Topics: AMP-Activated Protein Kinases; Animals; Aorta; Aortic Diseases; Atherosclerosis; Biomarkers; Blood Glucose; Chemokine CCL2; Cholestanes; Cholesterol; Diet, High-Fat; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Genetic Predisposition to Disease; Homeostasis; Male; Mice, Knockout; Phenotype; Phosphorylation; Plaque, Atherosclerotic; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-akt; Receptors, LDL; Signal Transduction; Spermine; Time Factors; Triglycerides; Weight Loss

2017